Literature DB >> 1726555

CD3- leukocytes present in the human uterus during early placentation: phenotypic and morphologic characterization of the CD56++ population.

A King1, N Balendran, P Wooding, N P Carter, Y W Loke.   

Abstract

In this study, the CD3- LGL/NK cells present in the pregnant human uterus have been characterized. Phenotypic and morphologic analyses of decidual LGL revealed many similarities to the minor CD56bright+, CD16- subset in peripheral blood, but there were some important differences. The relative surface density of CD56+ is greatly increased on decidual LGL to 22x that found on the majority of CD56+ peripheral blood NK cells. The CD56bright+ cells in decidua show LGL morphology, whereas in peripheral blood, they are mainly agranular. Proliferation of CD56+ cells occurs predominantly during the nonpregnant secretory (luteal) phase, indicating these CD56+ uterine LGL do not migrate as terminally differentiated cells. The appearance of CD56+ cells was examined at the ultrastructural level using immunoelectron microscopy. Cells with phenotypic characteristics of decidual LGL occur in a higher percentage (1.11%) in the peripheral blood of women of reproductive age than in men (0.66%). On the basis of these results, it is proposed that the CD56bright+ uterine leukocytes represent a distinctive, hormonally regulated subset possibly adapted to control human placentation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1726555      PMCID: PMC2275834          DOI: 10.1155/1991/83493

Source DB:  PubMed          Journal:  Dev Immunol        ISSN: 1026-7905


  57 in total

1.  Menstrual cycle hormones induce changes in functional interactions between lymphocytes and decidual vascular endothelial cells.

Authors:  Marianne J van den Heuvel; Julie Horrocks; Siamak Bashar; Suzanne Taylor; Suzanne Burke; Kota Hatta; Jennifer E Lewis; B Anne Croy
Journal:  J Clin Endocrinol Metab       Date:  2005-02-01       Impact factor: 5.958

Review 2.  Placental-related diseases of pregnancy: Involvement of oxidative stress and implications in human evolution.

Authors:  Eric Jauniaux; Lucilla Poston; Graham J Burton
Journal:  Hum Reprod Update       Date:  2006-05-08       Impact factor: 15.610

Review 3.  The role of glycans in immune evasion: the human fetoembryonic defence system hypothesis revisited.

Authors:  Gary F Clark
Journal:  Mol Hum Reprod       Date:  2013-09-15       Impact factor: 4.025

4.  Expression of CD69 activation marker by endometrial granulated lymphocytes throughout the menstrual cycle and in early pregnancy.

Authors:  N Vassiliadou; J N Bulmer
Journal:  Immunology       Date:  1998-07       Impact factor: 7.397

5.  Gestational drive and the green-bearded placenta.

Authors:  D Haig
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

Review 6.  Molecular Cross-Talk at the Feto-Maternal Interface.

Authors:  Gendie E Lash
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-18       Impact factor: 6.915

7.  Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation.

Authors:  Shiqiu Xiong; Andrew M Sharkey; Philippa R Kennedy; Lucy Gardner; Lydia E Farrell; Olympe Chazara; Julien Bauer; Susan E Hiby; Francesco Colucci; Ashley Moffett
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

8.  NKG2D blockade inhibits poly(I:C)-triggered fetal loss in wild type but not in IL-10-/- mice.

Authors:  Jessica E Thaxton; Tania Nevers; Eliana O Lippe; Sandra M Blois; Shigeru Saito; Surendra Sharma
Journal:  J Immunol       Date:  2013-03-01       Impact factor: 5.422

9.  Conversion of peripheral blood NK cells to a decidual NK-like phenotype by a cocktail of defined factors.

Authors:  Ana Sofia Cerdeira; Augustine Rajakumar; Caroline M Royle; Agnes Lo; Zaheed Husain; Ravi I Thadhani; Vikas P Sukhatme; S Ananth Karumanchi; Hernan D Kopcow
Journal:  J Immunol       Date:  2013-03-13       Impact factor: 5.422

10.  Prednisolone Trial: Study protocol for a randomised controlled trial of prednisolone for women with idiopathic recurrent miscarriage and raised levels of uterine natural killer (uNK) cells in the endometrium.

Authors:  Ai-Wei Tang; Zarko Alfirevic; Mark A Turner; Jo Drury; Siobhan Quenby
Journal:  Trials       Date:  2009-11-10       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.